Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis

To assess correlation between brain lesions and clinical status with 1.5T and 3T magnetic resonance imaging (MRI).

[1]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[2]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[3]  A. Thompson,et al.  Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR , 2000, Multiple sclerosis.

[4]  R. Sperling,et al.  Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis , 2007, Multiple sclerosis.

[5]  D. Mohr,et al.  The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients , 2004, Multiple sclerosis.

[6]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[7]  B. Uttl,et al.  North American Adult Reading Test: Age Norms, Reliability, and Validity , 2002, Journal of clinical and experimental neuropsychology.

[8]  A. Kangarlu,et al.  Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. , 2007, AJNR. American journal of neuroradiology.

[9]  A. Benton.  Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .

[10]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[11]  M. Ron,et al.  Cognitive impairment in relapsing—remitting multiple sclerosis can be predicted by imaging performed several years earlier , 2008, Multiple sclerosis.

[12]  F. Barwick,et al.  Depression in multiple sclerosis: Review and theoretical proposal , 2008, Journal of the International Neuropsychological Society.

[13]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[14]  M Rovaris,et al.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[15]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[16]  C. Kuhl,et al.  Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis? , 2006, AJNR. American journal of neuroradiology.

[17]  Marco Rovaris,et al.  Cognitive impairment and structural brain damage in benign multiple sclerosis , 2008, Neurology.

[18]  R. Bakshi,et al.  Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change , 2005, Journal of the Neurological Sciences.

[19]  D. Alsop,et al.  Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study , 2009, Journal of the Neurological Sciences.

[20]  C P Langlotz,et al.  MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. , 1998, AJNR. American journal of neuroradiology.

[21]  B. Weinstock-Guttman,et al.  Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire , 2008, Multiple sclerosis.

[22]  Frederik Barkhof,et al.  MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) , 1999, Multiple sclerosis.

[23]  R. Benedict.  Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis , 2005, Journal of the International Neuropsychological Society.

[24]  F Barkhof,et al.  Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis , 2005, Multiple sclerosis.

[25]  Julián Benito-León,et al.  Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing , 2005, The Lancet Neurology.

[26]  Ron Dumont,et al.  Delis‐Kaplan Executive Function System , 2008 .

[27]  Elias R Melhem,et al.  Detection of simulated multiple sclerosis lesions on T2-weighted and FLAIR images of the brain: observer performance. , 2006, Radiology.

[28]  Seth E. Bouvier,et al.  Comparison of Multiple Sclerosis Lesions at 1.5 and 3.0 Tesla , 2003, Investigative radiology.

[29]  Massimo Filippi,et al.  Functional MRI in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[30]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[31]  R. Benedict,et al.  Validity of the Wisconsin Card Sorting and Delis–Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis , 2007, Journal of clinical and experimental neuropsychology.

[32]  Rohit Bakshi,et al.  3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis , 2009, NeuroImage.

[33]  Lublin Fd,et al.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .

[34]  Mike P. Wattjes,et al.  Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T , 2006, European Radiology.

[35]  Rohit Bakshi,et al.  MRI in multiple sclerosis: current status and future prospects , 2008, The Lancet Neurology.

[36]  L. Radloff.  The CES-D Scale , 1977 .

[37]  L. Jacobs,et al.  A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium , 1999, Multiple sclerosis.

[38]  R Bakshi,et al.  Normal Findings on Brain Fluid-Attenuated Inversion Recovery MR Images at 3T , 2009, American Journal of Neuroradiology.

[39]  R. Benedict,et al.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.

[40]  Ralph H B Benedict,et al.  Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.

[41]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[42]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[43]  Kyle C. Kern,et al.  Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.

[44]  F. Barkhof,et al.  Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? , 2008, Journal of Neurology.

[45]  P. Morgan,et al.  Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[46]  Fritz Schick,et al.  Tissue warming and regulatory responses induced by radio frequency energy deposition on a whole‐body 3‐Tesla magnetic resonance imager , 2007, Journal of magnetic resonance imaging : JMRI.

[47]  D. Gronwall.  Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[48]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[49]  R. Kikinis,et al.  Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. , 2001, Archives of neurology.